open access

Vol 93, No 8 (2022)
Research paper
Published online: 2022-06-28
Get Citation

Risk factors associated with neonatal infectious and respiratory morbidity following preterm premature rupture of membranes

Joanna Kacperczyk-Bartnik1, Pawel Bartnik1, Justyna Teliga-Czajkowska2, Aneta Malinowska-Polubiec1, Agnieszka Dobrowolska-Redo1, Ewa Romejko-Wolniewicz1, Janusz Sierdzinski3, Ksawery Golawski4, Krzysztof Czajkowski1
·
Ginekol Pol 2022;93(8):629-636.
Affiliations
  1. 2nd Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland
  2. Department of Obstetrics and Gynecology Didactics, Medical University of Warsaw, Poland
  3. Department of Medical Informatics and Telemedicine, Medical University of Warsaw, Poland
  4. Students’ Scientific Group affiliated to 2nd Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland

open access

Vol 93, No 8 (2022)
ORIGINAL PAPERS Obstetrics
Published online: 2022-06-28

Abstract

Objectives: Preterm premature rupture of membranes (pPROM) is associated with the increased risk of chorioamnionitis, foetal exposure to inflammation, and respiratory complications in preterm neonates. The aim of the study was to identify patients at highest risk of developing neonatal infectious and respiratory morbidity following pPROM and preterm birth.

Material and methods: It was a retrospective cohort study including 299 consecutive patients in singleton pregnancies complicated by preterm premature rupture of membranes and giving birth between 22nd and 36th gestational week. Analysed factors included maternal characteristics, obstetric history, gestational age at pPROM and at delivery, latency and management. Multivariate logistic regression models were applied in order to identify risk factors for severe infectious and respiratory neonatal complications.

Results: Earlier gestational age at pPROM is associated with increased probability of developing early-onset neonatal sepsis and pulmonary hypertension. Earlier gestational age at birth and lower birth weight were independent factors associated with neonatal respiratory distress syndrome. Positive cervical culture was identified as a risk factor for acute neonatal respiratory failure.

Conclusions: Gestational age at pPROM, gestational age at birth and birth weight were the leading factors influencing the risk of developing neonatal infectious and respiratory morbidity following preterm premature rupture of membranes.

Abstract

Objectives: Preterm premature rupture of membranes (pPROM) is associated with the increased risk of chorioamnionitis, foetal exposure to inflammation, and respiratory complications in preterm neonates. The aim of the study was to identify patients at highest risk of developing neonatal infectious and respiratory morbidity following pPROM and preterm birth.

Material and methods: It was a retrospective cohort study including 299 consecutive patients in singleton pregnancies complicated by preterm premature rupture of membranes and giving birth between 22nd and 36th gestational week. Analysed factors included maternal characteristics, obstetric history, gestational age at pPROM and at delivery, latency and management. Multivariate logistic regression models were applied in order to identify risk factors for severe infectious and respiratory neonatal complications.

Results: Earlier gestational age at pPROM is associated with increased probability of developing early-onset neonatal sepsis and pulmonary hypertension. Earlier gestational age at birth and lower birth weight were independent factors associated with neonatal respiratory distress syndrome. Positive cervical culture was identified as a risk factor for acute neonatal respiratory failure.

Conclusions: Gestational age at pPROM, gestational age at birth and birth weight were the leading factors influencing the risk of developing neonatal infectious and respiratory morbidity following preterm premature rupture of membranes.

Get Citation

Keywords

bronchopulmonary dysplasia; neonatal sepsis; pprom; premature birth; respiratory distress syndrome; respiratory insufficiency; transient tachypnea of the newborn

About this article
Title

Risk factors associated with neonatal infectious and respiratory morbidity following preterm premature rupture of membranes

Journal

Ginekologia Polska

Issue

Vol 93, No 8 (2022)

Article type

Research paper

Pages

629-636

Published online

2022-06-28

Page views

4092

Article views/downloads

431

DOI

10.5603/GP.a2022.0066

Bibliographic record

Ginekol Pol 2022;93(8):629-636.

Keywords

bronchopulmonary dysplasia
neonatal sepsis
pprom
premature birth
respiratory distress syndrome
respiratory insufficiency
transient tachypnea of the newborn

Authors

Joanna Kacperczyk-Bartnik
Pawel Bartnik
Justyna Teliga-Czajkowska
Aneta Malinowska-Polubiec
Agnieszka Dobrowolska-Redo
Ewa Romejko-Wolniewicz
Janusz Sierdzinski
Ksawery Golawski
Krzysztof Czajkowski

References (38)
  1. Kachikis A, Walker CL, McAdams RM, et al. Phenotypic overlap in neonatal respiratory morbidity following preterm premature rupture of membranes versus spontaneous preterm labor. J Matern Fetal Neonatal Med. 2021; 34(12): 1941–1948.
  2. Liljedahl M, Martin H, Magnuson A, et al. Endothelial function in children with a history of premature prolonged rupture of membranes and bronchopulmonary dysplasia--a pilot study. Acta Paediatr. 2008; 97(7): 909–914.
  3. Ogunyemi D, Murillo M, Jackson U, et al. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med. 2003; 13(2): 102–109.
  4. De Dooy J, Colpaert C, Schuerwegh A, et al. Relationship between histologic chorioamnionitis and early inflammatory variables in blood, tracheal aspirates, and endotracheal colonization in preterm infants. Pediatr Res. 2003; 54(1): 113–119.
  5. Kallapur SG, Bachurski CJ, Le Cras TD, et al. Vascular changes after intra-amniotic endotoxin in preterm lamb lungs. Am J Physiol Lung Cell Mol Physiol. 2004; 287(6): L1178–L1185.
  6. Kramer BW, Kaemmerer U, Kapp M, et al. Decreased expression of angiogenic factors in placentas with chorioamnionitis after preterm birth. Pediatr Res. 2005; 58(3): 607–612.
  7. Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics. 2009; 123(5): 1314–1319.
  8. Ohlin A, Björkman L, Serenius F, et al. Sepsis as a risk factor for neonatal morbidity in extremely preterm infants. Acta Paediatr. 2015; 104(11): 1070–1076.
  9. Shah J, Jefferies AL, Yoon EW, et al. Canadian Neonatal Network. Risk Factors and Outcomes of Late-Onset Bacterial Sepsis in Preterm Neonates Born at < 32 Weeks' Gestation. Am J Perinatol. 2015; 32(7): 675–682.
  10. Blencowe H, Cousens S, Oestergaard M, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012; 379(9832): 2162–2172.
  11. Blencowe H, Cousens S, Chou D, et al. Born Too Soon Preterm Birth Action Group. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health. 2013; 10 Suppl 1: S2.
  12. Lim WHo, Lien R, Huang YC, et al. Prevalence and pathogen distribution of neonatal sepsis among very-low-birth-weight infants. Pediatr Neonatol. 2012; 53(4): 228–234.
  13. Simonsen KA, Anderson-Berry AL, Delair SF, et al. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014; 27(1): 21–47.
  14. Hofer N, Zacharias E, Müller W, et al. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology. 2012; 102(1): 25–36.
  15. Kinsella J, Greenough A, Abman S. Bronchopulmonary dysplasia. Lancet. 2006; 367(9520): 1421–1431.
  16. Davis PG, Hutchison AA. Acute Neonatal Respiratory Failure. In: Rimensberger P. ed. Pediatric and Neonatal Mechanical Ventilation. Heidelberg: Springer, Berlin 2015.
  17. Wen SWu, Smith G, Yang Q, et al. Epidemiology of preterm birth and neonatal outcome. Semin Fetal Neonatal Med. 2004; 9(6): 429–435.
  18. Fanaroff AA, Martin RJ. Neonatal-perinatal medicine: Diseases of the fetus and infant. 10th ed. Saunders, United States 2014.
  19. Guglani L, Lakshminrusimha S, Ryan RM. Transient tachypnea of the newborn. Pediatr Rev. 2008; 29(11): e59–e65.
  20. Mourani PM, Abman SH. Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond. Curr Opin Pediatr. 2013; 25(3): 329–337.
  21. Imterat M, Wainstock T, Sheiner E, et al. Preterm prelabor rupture of membranes prior to early preterm delivery elevates the risk of later respiratory-related hospitalizations in the offspring. Pediatr Pulmonol. 2020; 55(3): 706–712.
  22. Jahromi BN, Ardekany MS, Poorarian S. Relationship between duration of preterm premature rupture of membranes and pulmonary maturation. Int J Gynecol Obstet. 2000; 68(2): 119–122.
  23. Can E, Oğlak SC, Ölmez F. Maternal and neonatal outcomes of expectantly managed pregnancies with previable preterm premature rupture of membranes. J Obstet Gynaecol Res. 2022 [Epub ahead of print].
  24. Yan C, Deng X, Hong F. Analysis of Maternal and Neonatal Outcome of Patients with Preterm Prelabor Rupture of Membranes. J Healthc Eng. 2022; 2022: 8705005.
  25. Manuck TA, Maclean CC, Silver RM, et al. Preterm premature rupture of membranes: does the duration of latency influence perinatal outcomes? Am J Obstet Gynecol. 2009; 201(4): 414.e1–414.e6.
  26. Baser E, Aydogan Kirmizi D, Ulubas Isik D, et al. The effects of latency period in PPROM cases managed expectantly. J Matern Fetal Neonatal Med. 2020; 33(13): 2274–2283.
  27. Niesłuchowska-Hoxha A, Cnota W, Czuba B, et al. A Retrospective Study on the Risk of Respiratory Distress Syndrome in Singleton Pregnancies with Preterm Premature Rupture of Membranes between 24+0 and 36+6 Weeks, Using Regression Analysis for Various Factors. Biomed Res Int. 2018; 2018: 7162478.
  28. Kacperczyk-Bartnik J, Bartnik P, Teliga-Czajkowska J, et al. Comparison of maternal characteristics, pregnancy course, and neonatal outcome in preterm births with and without prelabor rupture of membranes. Ginekol Pol. 2020; 91(9): 528–538.
  29. Al-Lawama M, AlZaatreh A, Elrajabi R, et al. Prolonged Rupture of Membranes, Neonatal Outcomes and Management Guidelines. J Clin Med Res. 2019; 11(5): 360–366.
  30. Lorthe E, Ancel PY, Torchin H, et al. Impact of Latency Duration on the Prognosis of Preterm Infants after Preterm Premature Rupture of Membranes at 24 to 32 Weeks' Gestation: A National Population-Based Cohort Study. J Pediatr. 2017; 182: 47–52.e2.
  31. Zhuang Lu, Li ZK, Zhu YF, et al. The correlation between prelabour rupture of the membranes and neonatal infectious diseases, and the evaluation of guideline implementation in China: a multi-centre prospective cohort study. Lancet Reg Health West Pac. 2020; 3: 100029.
  32. Polcwiartek LB, Smith PB, Benjamin DK, et al. Early-onset sepsis in term infants admitted to neonatal intensive care units (2011-2016). J Perinatol. 2021; 41(1): 157–163.
  33. Chackowicz A, Czuzoj-Shulman N, Abenhaim HA. The effects of tocolysis on neonatal septic death in women with PPROM: a retrospective cohort study. Arch Gynecol Obstet. 2018; 298(5): 897–902.
  34. Winn HN, Chen M, Amon E, et al. Neonatal pulmonary hypoplasia and perinatal mortality in patients with midtrimester rupture of amniotic membranes--a critical analysis. Am J Obstet Gynecol. 2000; 182(6): 1638–1644.
  35. Weiner E, Barrett J, Zaltz A, et al. Amniotic fluid volume at presentation with early preterm prelabor rupture of membranes and association with severe neonatal respiratory morbidity. Ultrasound Obstet Gynecol. 2019; 54(6): 767–773.
  36. Brown RG, Marchesi JR, Lee YS, et al. Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin. BMC Med. 2018; 16(1): 9.
  37. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet. 2001; 357(9261): 979–988.
  38. Hernández-Ronquillo L, Téllez-Zenteno JF, Weder-Cisneros N, et al. Risk factors for the development of bronchopulmonary dysplasia: a case-control study. Arch Med Res. 2004; 35(6): 549–553.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl